PRESS RELEASE
13 September 2023

Patent Dance Disclosures And Beyond: Recent Biosimilars Litigation At The District Court

GP
Goodwin Procter LLP

Contributor

At Goodwin, we partner with our clients to practice law with integrity, ingenuity, agility, and ambition. Our 1,600 lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigation and world-class advisory services in the technology, life sciences, real estate, private equity, and financial industries. Our unique combination of deep experience serving both the innovators and investors in a rapidly changing, technology-driven economy sets us apart.
The world of biosimilar litigation is back in full swing with several BPCIA lawsuits currently pending. This webinar covers strategies and considerations during pre-litigation disclosures
United States

October 12, 2023 | 12:00 PM - 1:00 PM ET

SUMMARY

The world of biosimilar litigation is back in full swing with several BPCIA lawsuits currently pending. This webinar covers strategies and considerations during pre-litigation disclosures under the BPCIA (the so-called "patent dance") and in BPCIA litigation with a particular focus on what we have learned from the most recent wave of BPCIA litigations. We will discuss considerations for the timing of filing an aBLA, strategies for disclosure during the patent dance and early litigation, and key issues during BPCIA litigation from a reference product sponsor and biosimilar applicant perspective.

Elaine Blais, Natasha Daughtrey and Alexandra Valenti will host this webinar.

CLE credit will be offered for California, Minnesota, New Jersey, New York and Pennsylvania.

Contributor

At Goodwin, we partner with our clients to practice law with integrity, ingenuity, agility, and ambition. Our 1,600 lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigation and world-class advisory services in the technology, life sciences, real estate, private equity, and financial industries. Our unique combination of deep experience serving both the innovators and investors in a rapidly changing, technology-driven economy sets us apart.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More